Sanofi - Aventis Groupe: Press Release: Sanofi continues to

Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1 Paris, April 28, 2022 Q1 2022 sales growth of 8.6% at CER driven by Dupixent and CHC

Related Keywords

Japan , Australia , United States , Hungary , United Kingdom , Paris , France General , France , Philadelphia , Pennsylvania , Belarus , Brazil , Delaware , China , Russia , Canada , Ukraine , America , Australian , Canadian , Chinese , Brazilian , Ukrainian , British , Russian , Japanese , Hungarian , Eva Schaefer Jansen , Myozyme Lumizyme , Corentine Driancourt , Nicolas Obrist , Felix Lauscher , Daiichi Sankyo , Institut Gustave Roussy , Paul Hudson , Sandrine Guendoul , Nathalie Pham , Sally Bain , Priya Nanduri , Foundation For The National Institutes Of Health , Md Anderson Cancer Center , Research Development , Sanofi Business Services , Astrazeneca , Industrial Affairs , European Union , Sanofi Global Health , Dana Farber Cancer Institute , Amunix Pharmaceuticals Inc , Drug Administration , Us District Court , Japanese Ministry Of Health , Coalition Against Childhood Cancer , Memorial Sloan Kettering Cancer Center , Blackstone Life Sciences , Corporate Social Responsibility , Priority Review , Chief Executive Officer , Prurigo Nodularis , Eosinophilic Esophagitis , Global Business Unit , Specialty Care , General Medicines , Rare Disease , Orange Book , Rare Blood Disorders , Volume Based Procurement , Latin America , Translate Bio , Consumer Healthcare , Pain Care , Digestive Wellness , European Medicines Agency , Medicinal Products , Human Use , Biologics License Application , Japanese Ministry , Marketing Authorization Application , New England Journal , Warm Autoimmune Hemolytic Anemia , Amunix Pharmaceuticals , Pricing Principles , Pediatric Pre Clinical Proof , Concept Platform , Pediatric Oncology Relevant Target , National Institutes , Cancer Center , Memorial Sloan Kettering Cancer , Global Health , Life Cycle Analysis , Global Ratings , Social Profile , Gross Profit , Boehringer Ingelheim , Private Securities Litigation Reform Act , Statement Regarding Forward Looking , Human Resources , Information Solution , Cash Flow , Business Net Income , Sanofi , Eventis , Roupe , Dress , Release , Ontinues , Eliver , Strong , Business , Growth , Riven , Higher , Sales , Mproved , Margins ,